Related by context. All words. (Click for frequent words.) 71 vinca alkaloids 71 molecularly targeted 70 antiangiogenesis 70 mTOR inhibitors 69 proteasome inhibitors 69 cytostatic 68 receptor modulators 68 dasatinib Sprycel 67 multitargeted 67 CYT# potent vascular disrupting 67 IAP inhibitors 67 idarubicin 67 metaglidasen 67 histone deacetylase inhibitors 67 selective inhibition 67 vascular disrupting agents 67 receptor tyrosine kinase inhibitor 67 HSP# inhibitor 67 histone deacetylase HDAC inhibitors 66 systemic antifungal 66 Annamycin 66 alkylating agent 66 proteasome inhibitor 66 induce apoptosis 66 AEG# 66 AKT inhibitor 66 pharmacokinetic interactions 66 vinca alkaloid 66 antiangiogenic 66 anticancer agents 66 nucleoside analog 66 protein kinase inhibitor 65 Hsp# inhibitors 65 chemotherapeutic drug 65 mitotic kinesins 65 VEGF inhibitors 65 novel anticancer 65 flavopiridol 65 epothilones 65 OMP #M# 65 potent antiproliferative 65 Anti VEGF 65 cytoprotective 65 systemically administered 65 antimitotic 65 camptothecin 65 renin inhibitors 65 tyrosine kinase inhibitors 65 thalidomide Thalomid 65 selective inhibitors 65 Pertuzumab 65 MAGE A3 ASCI 65 LY# [003] 64 nucleoside analogs 64 CBLC# 64 IAP inhibitor 64 inhibit KSP 64 dexamethasone Decadron 64 PNP inhibitor 64 fibrinolytic 64 Gleevec resistant 64 cardiotoxic 64 highly selective endothelin 64 deacetylase inhibitors 64 anti TNF alpha 64 peripherally acting 64 K ras mutations 64 Fc fusion protein 64 microtubule targeting 64 mycophenolate mofetil 64 5 HT2B receptor 64 insulin sensitizers 64 angiogenesis inhibitor 64 epigenetic therapies 64 imatinib Gleevec 64 Panzem R NCD 64 PDE4 inhibitors 64 protein kinase inhibitors 64 Protease inhibitors 64 immune modulating 64 OMP #R# 64 evaluating tivozanib 64 cytotoxic 64 relapsed ovarian cancer 64 tumor vascular disrupting 64 cathepsins 64 ALK inhibitor 64 antimetabolite 64 Epothilones 64 antitumor 64 Temsirolimus 64 vorinostat 64 anti secretory 64 anticancer agent 64 SERMs 63 bortezomib Velcade 63 antidiabetic 63 pertuzumab 63 antitumour 63 MEK inhibitors 63 Vidaza azacitidine 63 pan HDAC inhibitor 63 tyrosine kinase inhibitor 63 CDK inhibitor 63 GRNOPC1 contains 63 JAK inhibitors 63 Romidepsin 63 immunomodulator 63 Lixivaptan 63 selective kinase inhibitor 63 histone deacetylases 63 preclinically 63 IV antihypertensive 63 multi kinase inhibitor 63 anticancer therapies 63 VDAs 63 orally administered inhibitor 63 taxane chemotherapy 63 anti angiogenic agents 63 bleomycin 63 enzyme inhibitor 63 OXi# 63 antiproliferative 63 myelofibrosis polycythemia vera 63 Seliciclib 63 HCV protease inhibitors 63 immunotherapeutic agent 63 NEUGENE 63 LHRH receptor positive 63 TNF blocking 63 interferon IFN 63 rifamycins 63 acadesine 63 lipoglycopeptide 63 nucleoside analogue 63 signal transduction inhibitor 63 small molecule tyrosine 63 Tumor Necrosis Factor 63 ENMD # 63 Locked Nucleic Acid LNA 63 antimetabolites 63 inhibits Akt activation 63 erlotinib Tarceva ® 63 inhibiting tumor 63 intravenous cyclophosphamide 63 cetuximab Erbitux R 63 IMA# 63 kinase inhibition 63 anti resorptive 63 immunomodulating 63 echinocandin 63 HDAC inhibitors 63 CD# expressing 63 TOCOSOL Camptothecin 63 HuLuc# 63 Blinatumomab 63 dasatinib Sprycel ® 63 sorafenib Nexavar 63 cytotoxic chemotherapy 63 intravenously administered 63 tyrosine kinase inhibitor TKI 63 novel immunomodulatory 63 echinocandins 63 triggers apoptosis programmed 63 humanised monoclonal antibody 63 oral prodrug 63 oral antidiabetic 63 nucleoside analogues 63 novel topoisomerase 63 HDACi 63 PEGylated 63 LY# [002] 63 marketed EGFR 63 BRAF inhibitors 63 cediranib 63 pomalidomide 63 alpha folate receptor 63 cilengitide 63 microtubule inhibitor 63 enzyme inhibitors 62 Sapacitabine 62 IMiDs ® 62 oral antiviral 62 PI3K/mTOR 62 Symadex 62 vascular disrupting agent 62 endocrine therapies 62 BCR ABL inhibitors 62 potent topoisomerase II 62 MMP inhibitors 62 potent cytotoxic 62 #ME# 62 investigational humanized monoclonal antibody 62 trastuzumab Herceptin ® 62 pegylated liposomal doxorubicin 62 FUSILEV enhances 62 factor TNF 62 LNP formulations 62 leukemia AML 62 novel VDA molecule 62 estramustine 62 LHRH antagonists 62 blood clot dissolving 62 trastuzumab Herceptin R 62 antiepileptic 62 antifolates 62 anti angiogenic drugs 62 aminoglycosides 62 immunomodulatory 62 fusion enhancers 62 rhIL 7 62 ganetespib 62 immuno modulatory 62 generation Hsp# inhibitor 62 chimeric monoclonal antibody 62 receptor inhibitor 62 imatinib Gleevec ® 62 antitumoral 62 myeloproliferative disorders 62 CA4P 62 inhibit metastasis 62 hedgehog pathway 62 Omacetaxine 62 Squalamine 62 EGF receptor 62 oncolytic vaccine 62 dihydrofolate reductase 62 IMiDs R 62 LHRH agonists 62 cyclophosphamide methotrexate 62 macrocyclic lactone 62 endothelin receptor antagonists 62 protein tyrosine phosphatase 1B 62 VA# [002] 62 TLR9 agonists 62 JAK2 inhibitor 62 Xanafide 62 NNRTIs 62 histone deacetylase HDAC 62 insulin sensitizing 62 HDAC inhibition 62 erlotinib Tarceva 62 NS4A 62 PI3K inhibitor 62 topoisomerase 62 Interferon alpha 62 antiresorptive 62 Aflibercept 62 fulvestrant 62 nilotinib Tasigna ® 62 selective modulator 62 Sudhir Agrawal D.Phil 62 CEQ# 62 epothilone 62 PEG SN# 62 uric acid lowering 62 gemcitabine Gemzar ® 62 Voreloxin 62 small molecule chemotherapeutic 62 orally bioavailable 62 ADP receptor antagonist 62 oxidative stress inducer 62 Epidermal Growth Factor Receptor 62 immunotoxin 62 tigecycline 62 IMiDs 62 adalimumab Humira 62 vWF 62 p# activation 62 Camptothecin 62 Bortezomib 62 Nanobody 62 mertansine 62 PSMA ADC 62 HER2 overexpression 62 TNF α 62 HGS# 62 budesonide foam 61 polyketide 61 antineoplastic 61 demonstrated antitumor activity 61 humanized monoclonal 61 anti CD3 61 CYC# 61 potentially hepatotoxic 61 antiandrogen 61 retaspimycin 61 Dasatinib 61 anti neoplastic 61 TLR8 61 anti TNF 61 HDAC6 61 Pemetrexed 61 Darinaparsin 61 DFMO 61 alkylating 61 paclitaxel Taxol 61 factor Xa inhibitor 61 PARP inhibitors 61 oral anti arrhythmic 61 TLR7 agonist 61 gamma secretase inhibitors 61 cytotoxins 61 cyclin dependent kinase inhibitor 61 TTR gene 61 Anti angiogenic 61 mTOR mammalian target 61 delta isoform 61 chemically modified siRNA 61 alvespimycin 61 chemotherapeutics 61 histone deacetylase inhibitor 61 TNFa 61 lenalidomide dexamethasone 61 posaconazole 61 intravenous bisphosphonates 61 metastatic renal cell carcinoma 61 gamma secretase inhibitor 61 RhuDex R 61 castrate resistant 61 novel peptide 61 IGF1R 61 kidney urologic 61 EGFR inhibitors 61 Enzastaurin 61 thrombopoietin 61 drug zotarolimus 61 tumor subtypes 61 anti leukemic 61 pharmacologically active isomer 61 Factor VIIa 61 doxorubicin HCl 61 agonistic human 61 alefacept 61 Mipomersen 61 ERK1 2 61 COX2 61 sulindac 61 antisense oligonucleotides 61 SARMs 61 accumulate preferentially 61 glucagon receptor 61 antithrombotic 61 tubulin inhibitor 61 taxol 61 TRAIL induced apoptosis 61 taxane derivative 61 YONDELIS 61 cardiac toxicity 61 immunomodulators 61 JAK2 enzyme 61 PDE4 inhibitor 61 immunomodulatory agents 61 fusion inhibitor 61 prodrugs 61 AV HALT 61 aurora kinase 61 tubulin binding 61 geldanamycin 61 muscarinic 61 CCR9 antagonist 61 signal transduction inhibitors 61 direct thrombin inhibitors 61 selective antagonist 61 liposome encapsulated 61 pathophysiological effects 61 Tumour Vascular Disrupting Agent 61 basiliximab 61 Aurora kinase inhibitor 61 targeting CD# 61 nucleotide analogs 61 HIV integrase inhibitors 61 benzimidazole 61 palifermin 61 riociguat 61 xenograft models 61 Tyrima 61 immunomodulatory properties 61 investigational monoclonal antibody 61 docetaxel chemotherapy 61 KSP inhibitor 61 MEK inhibitor 61 radiolabeled monoclonal antibody 61 macrolide antibiotics 61 HQK 61 subcutaneously administered 61 ATL# [001] 61 bendamustine ifosfamide 61 cannabinor 61 targeted radiotherapeutic 61 neuro protective 61 bendamustine 61 triphendiol 61 antirheumatic 61 oligodendrocyte progenitor cells 61 galiximab 61 mitochondrial toxicity 61 zoledronate 61 acute leukemias 61 NEUGENE antisense 61 AMPK activators 61 inhibit EGFR 61 Fludara ® 61 calcineurin inhibitors 61 Pazopanib 61 RhuDex TM 61 antiangiogenic therapy 61 HCV polymerase inhibitors 61 induces apoptosis 61 metastatic colorectal 61 FGFR 61 either acutely decompensated 61 olaparib 61 Fulvestrant 61 heparanase 61 huC# DM4 61 Sphingomab 61 Cloretazine R 61 panobinostat 61 Orally administered 61 TELINTRA 61 elotuzumab 61 CCR5 antagonist 61 depsipeptide 60 pegylated 60 antibody fragment 60 parthenolide 60 anticlotting 60 serine protease 60 PARP inhibitor 60 immune suppressive 60 daunorubicin 60 cyclic peptide 60 nonsteroidal 60 small molecule activators 60 Protein Kinase C 60 lumiliximab 60 FTIs 60 bevacizumab Avastin ® 60 anionic backbone 60 PXD# 60 phosphate S1P 60 Carcinoid tumors 60 Deforolimus 60 antitumor effects 60 anti proliferative 60 Akt activation 60 activate p# 60 Epratuzumab 60 novel tubulin binding 60 Talabostat 60 HMG CoA reductase inhibitors 60 Aurora Kinase 60 telomerase inhibition 60 anti amnesic 60 small molecule Hedgehog 60 CTAP# Capsules 60 peptidic 60 oncolytic 60 humanized anti 60 EZN 60 busulfan 60 pegfilgrastim 60 potent anticancer 60 relapsed MM 60 gemcitabine Gemzar 60 XmAb# 60 CDP# 60 bioactive lipids 60 auristatin 60 immunomodulation 60 CCR2 60 Pathway Inhibitor 60 exon skipping 60 beta 1a 60 cyclin dependent kinases 60 Mitoxantrone 60 corticosteroid dexamethasone 60 antisense therapies 60 leukemia CLL 60 cisplatin chemotherapy 60 Bucindolol 60 TLR9 agonist 60 Aurora kinase 60 liposomal formulation 60 trabectedin 60 biologic therapeutics 60 liposomal delivery 60 Fluorouracil 60 antiapoptotic 60 goserelin 60 Cloretazine 60 anti angiogenic 60 chemotherapeutic 60 ® lenalidomide 60 Bleomycin 60 PKC# 60 selective serotonin 2C receptor 60 Cytotoxic 60 IFN alpha 60 metastatic RCC 60 activin 60 M# rationally 60 Daclizumab 60 AAG geldanamycin analog 60 tyrosine kinase inhibitors TKIs 60 cytotoxic agents 60 beta interferons 60 peptidic compound 60 Anticalins R 60 selective inhibitor 60 Azacitidine 60 oral antifungal 60 vidofludimus 60 Vidaza ® 60 gefitinib Iressa 60 docetaxel Taxotere 60 potently inhibit 60 EOquin TM phase 60 BAY #-# 60 CGEN # 60 EGFR tyrosine kinase inhibitor 60 anthracycline taxane 60 CD# monoclonal antibody 60 selectively inhibits 60 mapatumumab 60 MGd 60 Smac mimetics 60 CORT # 60 anti fibrotic 60 VEGF receptor 60 CDK4 60 thymidylate synthase 60 Irinotecan 60 NMDA antagonist 60 APTIVUS r 60 bovine thrombin 60 Aplidin 60 CXCR4 receptor 60 lenalidomide Revlimid R 60 Granulocyte Colony Stimulating Factor 60 Anthracycline 60 SPRYCEL ® 60 III antiarrhythmic 60 EGFr 60 pimozide 60 thymidylate synthase TS 60 tricyclic 60 antisense inhibitors 60 5 HT4 60 anticancer activity 60 effector function 60 oral ghrelin agonist 60 thyroid hormone receptor 60 anti atherothrombotic 60 taxane resistant 60 GMX# 60 unresectable tumors 60 targeted antifolate 60 adriamycin 60 ligand TRAIL 60 ErbB3 HER3 60 cetuximab Erbitux ® 60 SYN# 60 SPC# [001] 60 antiangiogenic agent 60 oral Factor Xa 60 plus prednisone prednisolone 60 anti angiogenic therapies 60 PSN# [002] 60 maturation inhibitors 60 FLT3 60 Antiangiogenic 60 immune modulatory 60 targeting PCSK9 60 radezolid 60 GRN# 60 glucocorticoid receptors 60 intravesical instillation 60 THR beta agonist 60 oral Janus kinase 60 sphingosine 1 60 administered systemically 60 siRNA therapeutic 60 erythropoietic 60 anticancer therapy 60 5 FU leucovorin 60 oblimersen 60 receptor blocker 60 inhibit angiogenesis 60 fibrotic disease 60 JAK2 inhibitors 60 selectively inhibit 60 drug conjugate 60 RAF kinase 60 azoles 60 selectively inhibited 60 endothelin receptor 60 Cisplatin 60 xanthine oxidase inhibitor 60 cytarabine daunorubicin 60 PPARγ 60 cyclophosphamide chemotherapy 60 apoptosis inducer 60 uPA 60 tiapamil 60 Temozolomide 60 Apo2L 60 JAK#/JAK# 60 oral anticancer 60 hepatotoxicity 60 anthracycline chemotherapy 60 CYP #A# 60 lipopeptides 60 neuro inflammatory 60 RhuDex ® 59 antagomirs 59 EGFR tyrosine kinase inhibitors 59 oral JAK1 59 chemopreventive agent 59 bevacizumab Avastin R 59 AQ4N 59 NMDA antagonists 59 Alfacell proprietary ribonuclease 59 antisense drug 59 humanized antibody 59 telomerase therapeutic 59 EGFR TKIs 59 nalbuphine ER 59 trans retinoic acid ATRA 59 antitumor efficacy 59 CD# antibody [001] 59 itraconazole Sporanox 59 fusion proteins 59 incretin 59 HGS ETR1 59 eIF 4E 59 humanized monoclonal antibodies 59 trans retinoic acid 59 mRCC 59 TNF alpha antagonist 59 osteosarcomas 59 GW# [003] 59 inhibitor RG# 59 etanercept Enbrel 59 NuMimetic TM 59 Myolimus 59 THALOMID ® 59 tumor vasculature 59 mGluR2 NAM 59 proliferative disorders 59 interferon alfa 59 antiproliferative effects 59 pDCs 59 5alpha reductase 59 neuroactive 59 lipid lowering therapies 59 angiogenesis inhibition 59 anti tubercular 59 Chemotherapeutic 59 intradermal injection 59 FVIIa 59 antiangiogenic agents 59 LPA1 receptor 59 apoptosis inducing 59 LHRH agonist 59 ESBA# 59 generation purine nucleoside 59 radioprotective 59 ALN TTR# 59 infliximab Remicade 59 TG# [003] 59 HCV protease 59 trastuzumab Herceptin 59 therapeutic monoclonal antibody 59 CXB# 59 MTP inhibitor 59 ATL/TV# 59 anti VEGF 59 Dapagliflozin 59 insulin sensitizer 59 peptibody 59 bone metastasis 59 Safinamide 59 seliciclib 59 Valproic acid 59 bile acid sequestrants 59 bexarotene 59 prescribed proton pump 59 itraconazole 59 HGS ETR1 mapatumumab 59 glucocorticoid receptor 59 alkylating agents 59 GnRH antagonist 59 Methylnaltrexone 59 RNA antagonists 59 Sym# 59 imatinib therapy 59 anti EGFR antibody 59 CG# [003] 59 heavily pretreated 59 Aviptadil 59 Vincristine 59 radiolabeled 59 IMiDs ® compound 59 treating neuropathic pain 59 SAR# [004] 59 oral proteasome inhibitor 59 PDE4 59 recurrent glioblastoma multiforme 59 gonadotrophin releasing hormone 59 Nexavar sorafenib 59 Degarelix 59 nilotinib Tasigna 59 injectable intravascular contrast 59 doxorubicin Adriamycin 59 hormone refractory 59 indibulin 59 synthetic retinoid 59 glatiramer 59 incretin mimetics 59 immunosuppressive 59 PSN# [001] 59 CRAC channel 59 sitaxsentan 59 Cytarabine 59 JAK3 59 macrolide antibiotic 59 Doxil ® 59 modulates Akt 59 druggable target 59 selective relaxant 59 PD LID 59 Preclinical studies suggest 59 small molecule inhibitors 59 CYP#A# substrate 59 flutamide 59 Src inhibitors 59 docetaxel Taxotere ® 59 NS#/#A protease 59 antibody cytokine 59 superficial bladder cancer 59 specific lectin receptors 59 rufinamide 59 Velcade bortezomib 59 polyketides 59 TNFα 59 DACH platinum 59 ribonuclease 59 oxazolidinone 59 Akt inhibitor 59 Nanobody ® 59 hepatoma 59 antihormonal 59 organ transplant rejection 59 TNF blocker therapy 59 taxane chemotherapy administered 59 NeoLipid TM 59 tau aggregates 59 partial agonist 59 regorafenib 59 HIV protease 59 relapsed ALL 59 IGF 1R 59 ADAMTS# 59 targeted biologic therapies 59 vinblastine 59 Vaprisol 59 skeletal metastases 59 androgen receptor antagonist 59 Vidofludimus 59 potent neuroprotective 59 Curaxin 59 liposomal 59 TRV# [001] 59 gemcitabine cisplatin 59 ImmunoGen DM1 cancer 59 SSc 59 PGE2 59 EndoTAG TM -1 59 alpha#beta# integrin 59 cortisol synthesis 59 cMET 59 selective androgen receptor modulator 59 secondary hyperparathyroidism 59 heparins 59 endostatin 59 HDACs 59 Hsp# inhibitor 59 cabazitaxel 59 immune stimulatory 59 OvaRex R 59 IGF IR 59 fusion inhibitors 59 SCCHN 59 hormone LHRH antagonist 59 peptide hormone 59 aza anthracenedione molecular 59 related apoptosis inducing 59 inverse agonists 59 Human cl 59 selective androgen receptor modulators 59 Laquinimod 59 PI3K/Akt pathway inhibitor 59 antithrombotics 59 Janus Kinase 59 dopamine D1 59 pegylated interferons 59 predictive biomarkers 59 GSK3B 59 Camptosar ® irinotecan 59 SNT MC# 59 SinuNase ™ 59 immunostimulatory 59 5 fluorouracil leucovorin 59 virus HCV protease inhibitor 59 JAK1 59 OXIGON TM 59 nucleoside 59 Ixabepilone 59 IL-#/# 59 p# mitogen activated 59 non hodgkin lymphoma 59 Tacrolimus 59 protein mTOR 59 pharmacodynamic biomarkers 59 prostaglandin E2 59 nucleoside reverse transcriptase inhibitor 59 Pagoclone 59 refractory NSCLC 59 radiosensitivity 59 telomerase inhibitor 59 idraparinux 59 engineered RAP peptides 59 5 HT6 receptor 59 CDDO Im 59 demethylating agent 59 oral dihydropyrimidine dehydrogenase DPD 59 non porcine pancreatic 59 RNAi therapeutic targeting 59 oral immunomodulatory 59 BRAF kinase 59 amphotericin B 59 SGLT 2 59 nutlin 3a 59 Abl 59 candidate deforolimus 59 c MET 59 carboplatin paclitaxel 59 apoptosis proteins 59 HSP# inhibitors 59 liposomal doxorubicin 59 forodesine 59 substrates inhibitors 59 DHFR 59 topoisomerase II 59 c MYC 59 IFN beta 59 tryptase 59 Trabectedin 59 Zolinza 58 RTP #i 58 EP1 receptor 58 pyrazinamide 58 talabostat 58 antifibrotic 58 inhibit replication 58 CIMZIA ™ 58 pyridostigmine 58 teriflunomide 58 act synergistically 58 optimized siRNA 58 Bevacizumab 58 reuptake inhibitors 58 vinorelbine tartrate 58 mutated KRAS 58 vapreotide acetate 58 Ophena TM 58 multikinase inhibitor 58 colon carcinoma 58 cisplatin resistant 58 modulators SERMs 58 antifibrinolytic 58 Octreotide 58 Kinoid 58 LHRH 58 ELACYT 58 LEP ETU 58 chemoresistant 58 CCX# 58 ritonavir boosted 58 plasma kallikrein 58 5FU 58 Tesmilifene 58 microtubule dynamics 58 Etoposide 58 bicalutamide 58 Dacogen decitabine 58 OncoVEX GM CSF 58 sorafenib Nexavar ® 58 anti angiogenesis 58 virotherapy 58 granisetron 58 Onconase 58 recurrent glioblastoma multiforme GBM 58 A3 adenosine receptor 58 EGFR pathway 58 ALK inhibitors 58 Abiraterone 58 antisense compounds 58 R sorafenib tablets 58 Anticalins 58 E#F# 58 DOS# 58 Intravenous CP 58 orally dosed 58 apoptosis induced 58 anticancer therapeutics 58 velafermin 58 omega interferon 58 TKIs 58 vaso occlusive crisis 58 receptor agonists 58 p# MAPK 58 NS5b 58 humanized monoclonal antibody 58 TACI Ig 58 selective estrogen receptor modulators 58 prokinetic 58 candidates Azedra TM 58 BLyS specific 58 Anidulafungin 58 recurrent glioblastoma 58 Cremophor 58 Atrasentan 58 kinase inhibitor 58 Atripla combines 58 PI3K Akt 58 mTOR inhibitor 58 Panzem 58 maximally tolerated lipid lowering 58 Fludarabine 58 IL 1ß 58 thrombopoietin TPO 58 taxanes 58 immune modulators 58 bispecific 58 γ secretase 58 platelet aggregation inhibitors 58 daptomycin 58 p# inhibitors 58 p# inhibitor 58 Stapled Peptide 58 #beta HSD1 58 obatoclax 58 Herceptin trastuzumab 58 resolvins 58 indinavir 58 Vorinostat 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 Epstein Barr Virus EBV 58 Bezielle 58 isoform selective 58 anti sickling 58 Natalizumab 58 anti hyperglycemic 58 Zorbtive TM 58 MMAE 58 Proxinium TM 58 visilizumab 58 XL# XL# 58 Cytoxan 58 BCR ABL inhibitor 58 triphosphate 58 Aliskiren 58 Th2 cytokines 58 Monoclonal antibody 58 Factor Receptor 58 Photodynamic therapy PDT 58 SUTENT ® 58 cytolytic 58 PORxin 58 anti angiogenic agent 58 endosomal release 58 metalloprotease 58 renin inhibitor 58 GRNVAC1 58 protein receptors lectins 58 small molecule defensin 58 VitiGam 58 luteinizing hormone releasing 58 fluticasone furoate 58 synthetic analogues 58 BNC# 58 histone deacetylase 58 OvaRex ® MAb 58 receptor antagonists 58 hematological malignancy 58 integrin receptors